Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clearmind Medicine, Inc.

1.18
-0.0201-1.67%
Volume:3.51K
Turnover:4.13K
Market Cap:5.54M
PE:-0.70
High:1.20
Open:1.19
Low:1.15
Close:1.20
Loading ...

Company Profile

Company Name:
Clearmind Medicine, Inc.
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
- -
Office Location:
1220 West 6th Avenue,Suite 101,Vancouver,British Columbia,Canada
Zip Code:
V6H 1A5
Fax:
- -
Introduction:
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company has a collaboration with Clearmind Medicine Inc. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Directors

Name
Position
Amitay Weiss
Chairman of the Board
Asaf Itzhaik
Director
Oz Adler
Director
Yehonatan Shachar
Director

Shareholders

Name
Position
Adi Zuloff Shani
Chief Executive Officer
Alan Rootenberg
Chief Financial Officer
Mark Haden
Vice President of Business Development